<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>High macrophage infiltration into <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> often correlates with poor prognoses; in colorectal, stomach and <z:e sem="disease" ids="C0007114" disease_type="Neoplastic Process" abbrv="">skin cancers</z:e>, however, the opposite is observed but the mechanisms behind this phenomenon remain unclear </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we sought to understand how <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-associated macrophages (TAMs) in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> execute <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressive roles </plain></SENT>
<SENT sid="2" pm="."><plain>We found that TAMs in a <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> model were pro-inflammatory and inhibited the proliferation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>TAMs also produced chemokines that attract T cells, stimulated proliferation of allogeneic T cells and activated type-1 T cells associated with anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> immune responses </plain></SENT>
<SENT sid="4" pm="."><plain>Using <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumour</z:e> tissues, we verified that TAMs in vivo were indeed pro-inflammatory </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, the number of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-infiltrating T cells correlated with the number of TAMs, suggesting that TAMs could attract T cells; and indeed, type-1 T cells were present in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissues </plain></SENT>
<SENT sid="6" pm="."><plain>Patient clinical data suggested that TAMs exerted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressive effects with the help of T cells </plain></SENT>
<SENT sid="7" pm="."><plain>Hence, the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressive mechanisms of TAMs in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> involve the inhibition of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell proliferation alongside the production of pro-inflammatory cytokines, chemokines and promoting type-1 T-cell responses </plain></SENT>
<SENT sid="8" pm="."><plain>These new findings would contribute to the development of future <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> immunotherapies based on enhancing the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressive properties of TAMs to boost anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> immune responses </plain></SENT>
</text></document>